Clinical trials: Multi-resistant Enterobacteriaceae Colonisation
Enterobacteriaceae Infections, Multi-antibiotic Resistance
FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae
Rates of antimicrobial resistance are increasing worldwide. There is increasing evidence that physiological gut microbiota is a large reservoir of antibiotic-resistance genes.
- Trial name
- FMT-CRE (NCT04759001)
- Testing
- Donor FMT
- Where
- Italy
- Volunteers
- 52 people
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Carbapenem-Resistant Enterobacteriaceae, Colonisation
Tackling Resistance And HealthCare Economics Through CPE Screening
The goal of this clinical study is to learn if it is possible to reduce the spread of resistant bacteria called CPEs (Carbapenemase producing Enterobacterales) between patients admitted to hospital.
- Trial name
- TRACE-CPE (NCT07663110)
- Testing
- Rapid molecular diagnostic test for CPE identification
- Where
- 2 sites in United Kingdom
- Volunteers
- 16,000 people
- Sponsor
- Imperial College London
Multi-resistant Enterobacteriaceae Colonisation, Pregnancy
Multi-resistant Enterobacteriaceae Colonisation in Less Than 32 Weeks Pregnant Women Admitted to the Hospital.
The purpose of this study is to determine the prevalence and risk factors for multi-resistant enterobacteriaceae colonization in less than 32 weeks pregnant women admitted to the hospital and its transmission to the newborn, in…
- Conditions
- Multi-resistant Enterobacteriaceae Colonisation, Pregnancy, Nosocomial Outbreaks
- Trial name
- EME (NCT02631226)
- Where
- Spain
- Volunteers
- 580 people
- Sponsor
- Corporacion Parc Tauli